HSBC Holdings’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
VPM
VCM
AIM
HSBC Holdings's VCYT Position: Q1 2026 in Review
HSBC Holdings reduced its Veracyte (VCYT) stake by 5.3% in Q1 2026, selling an estimated $27.2K and leaving 13,186 shares worth $424K. The position accounts for ﹤0.01% of the portfolio, ranked #2293.
HSBC Holdings first reported a position in VCYT in Q2 2020 and has held it in 12 quarters since. The position peaked at $660K in Q2 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.
- HSBC Holdings held 13,186 shares of Veracyte worth $424K as of Q1 2026.
- HSBC Holdings sold 736 Veracyte shares in Q1 2026, an estimated $27.2K.
- Veracyte made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2293 holding.
- HSBC Holdings first reported a position in Veracyte in Q2 2020 and has held it in 12 quarters since.
- HSBC Holdings's Veracyte position peaked at $660K in Q2 2025.
- 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.